UPDATE 3-Japan's Takeda to buy U.S. cancer drug maker Ariad in $5.2 bln deal

Jan 9 (Reuters) - Japan's Takeda Pharmaceutical Co Ltd said it would buy cancer drug maker Ariad Pharmaceuticals Inc in a deal valued at $5.20 billion, to beef up its oncology pipeline. [Source]

Origin: reuters.com

Category: hotStocksNews

Topics: maker, cancer, Takeda, pipeline, oncology, billion, valued, Ariad Pharmaceuticals, would, Pharmaceutical, Japan's, (Reuters), Ariad, 3-Japan's, UPDATE

Source: http://feeds.reuters.com/~r/reuters/hotStocksNews/~3/uWfuIUeWA7o/ariad-pharm-ma-takeda-pharma-idUSL4N1EZ3G6